Global epidemiology of dyslipidaemias

A Pirillo, M Casula, E Olmastroni, GD Norata… - Nature Reviews …, 2021 - nature.com
Dyslipidaemias are alterations to the plasma lipid profile that are often associated with
clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are …

Mediterranean diet and obesity-related disorders: what is the evidence?

G Muscogiuri, L Verde, C Sulu, N Katsiki… - Current obesity …, 2022 - Springer
Abstract Purpose of Review Obesity is a chronic disease, a major public health problem due
to its association with non-communicable diseases and all-cause mortality. Indeed, people …

The power of genetic diversity in genome-wide association studies of lipids

SE Graham, SL Clarke, KHH Wu, S Kanoni, GJM Zajac… - Nature, 2021 - nature.com
Increased blood lipid levels are heritable risk factors of cardiovascular disease with varied
prevalence worldwide owing to different dietary patterns and medication use. Despite …

Report on cardiovascular health and diseases in China 2021: an updated summary

HU Sheng-Shou - Journal of Geriatric Cardiology, 2023 - jgc301.com
Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to …

[HTML][HTML] Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative …

B Zhou, RM Carrillo-Larco, G Danaei, LM Riley… - The Lancet, 2021 - thelancet.com
Background Hypertension can be detected at the primary health-care level and low-cost
treatments can effectively control hypertension. We aimed to measure the prevalence of …

[HTML][HTML] Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million …

B Zhou, AW Rayner, EW Gregg, KE Sheffer… - The Lancet, 2024 - thelancet.com
Background Diabetes can be detected at the primary health-care level, and effective
treatments lower the risk of complications. There are insufficient data on the coverage of …

Epidemiological features of cardiovascular disease in Asia

D Zhao - JACC: Asia, 2021 - jacc.org
Cardiovascular disease (CVD) is the leading cause of death in Asia. To combat the harmful
impacts of CVD on public health in Asian countries with more effective strategies and …

Report on cardiovascular health and diseases in China 2021: an updated summary

TWC of the Report - Biomedical and Environmental Sciences, 2022 - Elsevier
Abstract In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all
deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD …

[HTML][HTML] PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021

M Banach, P Burchardt, K Chlebus… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Moreover, over the last few years the approach to treatment of patients with a high
cardiovascular risk has totally changed from treatment aimed at a specific risk factor (ie …

[HTML][HTML] World heart federation cholesterol roadmap 2022

KK Ray, BA Ference, T Séverin, D Blom, SJ Nicholls… - Global …, 2022 - ncbi.nlm.nih.gov
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial
infarction, stroke and peripheral arterial disease continue to be major causes of premature …